Race To Treat Alzheimer’s Disease Is Heating Up Despite Eli Lilly’s Setback
Investor's Business DailyThe Alzheimer’s treatment space is heating up — and could soon leave Eli Lilly’s embattled drug, donanemab, in the dust, experts say.
The post Race To Treat Alzheimer's Disease Is Heating Up Despite Eli Lilly's Setback appeared first on Inves…